MedTrace Logo

A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells

NCT06163508 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2026-04-21

No results posted yet for this study

Summary

This study is an observational study designed to obtain information on the long-term safety, tolerability, and continued activity of Q-Cells®. The study will follow the participants who previously received Q-Cells® for 10 years.

The goal of this observational study is to learn about the long term effects of Q-Cells® in people with transverse myelitis.

The main objectives the study is to evaluate the safety of patients who have received Q-Cells®.

The secondary goal of the study is to get data about the long-term activity of Q-Cells® over a period of 10 years.

Patients will complete exams, lab tests, imaging, and questionnaires to monitor their safety.

Conditions

  • Transverse Myelitis

Interventions

DRUG

Q-Cells®

Long term observational study of patients who received 1 of 3 different amounts of Q-Cells®.

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Benjamin Greenberg, MD · University of Texas Southwestern Medial Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-12
Primary Completion
2035-12-31
Completion
2035-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06163508 on ClinicalTrials.gov